Pharmaron overview on in vitro safety panel screening, offering early identification of off-target effects to reduce drug candidate liabilities in development.

in vitro Safety Panel

in vitro Safety Profiling Services for Identification of Off-Target Effects to Reduce Safety Liabilities Early

Pharmaron’s in vitro safety panel and pharmacology profiling services provide a critical step in drug discovery and development, designed to assess potential safety liabilities of new therapeutic compounds. These services enable researchers to identify off-target interactions through comprehensive off-target screening that could impact drug safety, supporting data-driven decisions for lead optimization and candidate selection.

Key Features of our Safety Pharmacology Panel for in vitro Safety Profiling:

  • Comprehensive off-target screening with functional and binding assay options for all targets.
  • Two standard panels (44 and 94 targets) with the option of panel customization.
  • Broad target coverage, including GPCRs, nuclear hormone receptors, kinases, enzymes, transporters, and ion channels.
  • Cost-effective solution with turnaround times of only 3 weeks (for the 44-target panel) and flexible start dates

Download our flyer to discover how Pharmaron’s in vitro safety profiling services can support your drug discovery and development project.

Download Our Service Overview